Financial Performance - Kirby's Q2 2025 revenues increased by 4% year-over-year to $855.5 million[5] - Operating income for Q2 2025 rose by 9% year-over-year to $131.8 million[5] - Net earnings attributable to Kirby in Q2 2025 increased by 12% year-over-year to $94.3 million[5] - Earnings per share for Q2 2025 increased by 17% year-over-year to $1.67[5] - Kirby repurchased $31 million of its stock during the quarter[6] Marine Transportation - Inland marine transportation contributed 81% of marine transportation revenues[21] - Coastal marine transportation contributed 19% of marine transportation revenues[21] - Inland barge utilization was in the low to mid-90% range[21] - Coastal barge utilization was in the mid to high-90% range[21] - Term contract renewals for inland were up in the low to mid-single digits year-over-year[11] - Term contract renewals for coastal were up in the mid-20% range year-over-year[11] Distribution & Services - Distribution & Services revenues increased by 7% year-over-year to $362.9 million[25] - Power generation revenues increased by 31% year-over-year[17] - Oil and Gas revenues decreased by 27% year-over-year[17] Balance Sheet and Liquidity - Total debt stood at $1.1 billion as of June 30, 2025[30] - Available liquidity was $332 million as of June 30, 2025[30]

Financial Performance - Q2 2025 revenue reached $15.2 million, nearly equivalent to the entire FY24 revenue[11], representing a 46% increase compared to Q1 2025's $10.5 million[22] - Total cash increased by 218% to $183.2 million compared to Q2 2024[11] - Adjusted EBITDA loss was $(51.6) million, with a margin of (339%), a 75 percentage point improvement QoQ[22] - Gross loss was $(31.0) million, with a margin of (203%), a 32 percentage point improvement QoQ[22] Commercial Growth - The commercial pipeline increased to $18.8 billion, representing approximately 77 GWh[11], a 21% increase from the previous quarter[21] - Orders backlog reached $672.5 million, representing approximately 2.6 GWh[11] - The lead generation pipeline is $15.1 billion, representing approximately 61 GWh, a 12% increase QoQ[21] Operational Improvements - Achieved a 40% improvement in discharge energy from launch[14] - The company is transitioning to CM positive cubes, increasing throughput and improving utilization[16] - Sub-assembly automation is driving faster throughput, improved consistency, and product performance, with a 64% improvement in part flatness[17]

Company Overview - Kimco Realty's total capitalization is $23.1 billion [7] - The company has 567 properties with 101 million square feet of gross leasable area (GLA) [7] - Kimco's strategy focuses on necessity-based goods and services, strong balance sheet, and expansion in high barrier-to-entry markets [8] Financial Performance - The company experienced 7.3% growth in FFO/diluted share compared to Q2 2024 [13] - Kimco has $2.2 billion in immediate liquidity [13] - The company's net debt to EBITDA is 5.6x on a look-through basis [13] Portfolio & Leasing - The company achieved a record high 86% ABR from grocery-anchored centers [13, 37] - Small shop occupancy reached a record high of 92.2% [13] - The blended pro-rata rent spread on comparable leases was 15.2% [13] - The signed not opened (SNO) pipeline is valued at $66 million [10, 13, 59] Capital Allocation - The company anticipates $100 million to $125 million in net acquisitions in 2025 [10, 79] - Kimco plans to sell $100 million to $150 million of low-growth assets [10, 79] - Redevelopment projects are expected to yield 17% and anchor space repositioning projects are expected to yield 11% [10]

Financial Performance Highlights - ITT reported over $1 billion in orders for the second consecutive quarter, driven by share gains[7] - The company is raising its full-year adjusted EPS midpoint by 15 cents to $6.45, a 10% increase compared to the previous year[7] - Q2 2025 adjusted EPS grew by 10%[8] - Year-to-date free cash flow reached $214 million, a 30% increase compared to the previous year[9] Growth Metrics - Organic orders grew by 13% in Q2 2025, while total orders grew by 16%[8] - Organic revenue growth was 4%, with total revenue growth at 7%[8] - IP organic growth was 22%, with pump projects showing a 62% increase[9] - CCT organic growth was 9%, driven by defense and aerospace awards[9] Margin and Profitability - The adjusted operating margin was 18.4%, representing a 30 bps expansion[8] - IP adjusted operating margin was 21.8%, a 100 bps increase[9] - MT adjusted operating margin was 20.2%, a 140 bps increase[9] - CCT adjusted operating margin increased by 270 bps excluding acquisition dilution[9] Capital Deployment - ITT repurchased $500 million of its own shares year-to-date, reducing the share count by 3%[9] - The company expects to generate $0.5 billion of full-year free cash flow[9] Guidance and Targets - The company is raising its 2025 revenue growth guidance to +5% to +7%, with organic growth expected to be +3% to +5%[24] - ITT is targeting revenue growth of >5% CAGR for its base business and ~10% CAGR with compounding M&A by 2030[11] - The company is aiming for an adjusted EPS of >$11 for the base business and >$12 with M&A by 2030[11]

Second Quarter 2025 Financial Results Conference Call July 31, 2025 Forward-Looking Statements This presentation contains certain "forward-looking statements" (as such term is defined in Section 21E of the Securities Exchange Act of 1934, as amended). All statements, other than statements of historical facts, that address activities, events or developments that Costamare Inc. (the "Company") expects, projects, believes or anticipates will or may occur in the future, including, without limitation, future ope ...

References in this presentation ("Presentation") to "TSLX," "we," "us," "our" and "the Company" refer to Sixth Street Specialty Lending, Inc. EARNINGS PRESENTATION Quarter Ended June 30, 2025 This Presentation includes forward-looking statements about TSLX that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about us, our current and prospective portfolio investments, our industry, ...

Q2 2025 Performance Highlights - XPO's operating income reached $198 million, a 1% increase year-over-year[8,9] - The LTL adjusted operating ratio improved by 30 bps year-over-year to 82.9%[8,9] - LTL adjusted EBITDA increased by 1% year-over-year to $300 million[8,9] - LTL purchased transportation expense decreased by 53% year-over-year[8] - LTL linehaul miles outsourced to third-party carriers decreased by 910 bps year-over-year[8,43] - LTL yield, excluding fuel, increased by 6.1% year-over-year[8,39] Strategic Growth Plan & Targets - The company aims for a revenue CAGR of 6% to 8% and an adjusted EBITDA CAGR of 11% to 13% for LTL growth from 2021 to 2027[12,44] - The company is targeting an adjusted operating ratio improvement of at least 600 bps for LTL from 2021-2027[12] - The company plans to target capex of 8% to 12% of revenue on average through 2027[29] Industry Position - The North American LTL industry is a $53 billion industry, with the top 10 players holding over 75% market share[18] - The company's North American LTL segment has a 9% industry share, generating $4.9 billion in revenue in 2024[19] 2025 Outlook - The company anticipates total gross capex between $600 million and $700 million for the full year 2025[50] - The company expects interest expense between $220 million and $230 million for the full year 2025[50] - The company projects a diluted share count of 120 million for the full year 2025[50]

Second Quarter 2025 Earnings Presentation Enabling Technology. Growing Sustainably. Legal Notices SAFE HARBOR Please note that in this presentation, we may discuss events or results that have not yet occurred or been realized, commonly referred to as forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of the Company. Such discussion and statements will often contain words such as "expect," "anticipate," " ...

Financial Highlights - S&P Global's revenue increased by 6% year-over-year[18], reaching $3755 million[42] - Subscription product revenue grew by 7% year-over-year[18] - Adjusted operating profit increased by 7% year-over-year[18], from $1749 million to $1823 million[44] - Adjusted diluted EPS increased by 10% year-over-year[18], reaching $4.43[45] - The company returned nearly $950 million to shareholders through dividends and share repurchases[18] Segment Performance - Market Intelligence revenue increased by 5%[42], totaling $1217 million[50], with organic constant currency revenue growth of 7%[51] - S&P Global Ratings revenue increased by 1%[42], reaching $1148 million[56], with transaction revenue decreasing by 4% year-over-year and non-transaction revenue increasing by 8% year-over-year[57] - Commodity Insights revenue increased by 8%[42], totaling $555 million[61], with organic constant currency revenue growth of 8%[62] - Mobility revenue increased by 10%[42], reaching $438 million[65], with organic constant currency revenue growth of 10%[66] - S&P Dow Jones Indices revenue increased by 15%[42], totaling $446 million[70], with organic constant currency revenue growth of 15%[71] Strategic Initiatives - Active users of Spark Assist have increased from approximately 30% to over 65%[33] - The number of internally published use cases, or "Sparks", has increased from 1300 to more than 3000[33] Market Conditions - Billed issuance decreased by 4%[24], from $1062 billion to $1017 billion[22]

Financial Performance - Total Q2 Net Product Revenues reached $672 million, a 64% increase year-over-year[17, 24] - Total TTR Net Revenues in Q2 were $544 million, representing a 77% year-over-year growth[17] - Rare Franchise Net Product Revenues in Q2 totaled $128 million, a 24% increase year-over-year[28] - Alnylam increased its 2025 Total Net Product Revenue Guidance to a range of $2650 million to $2800 million[17, 74] - The company's Q2 Non-GAAP Operating Income was $95 million[70] Commercial Highlights - U S ATTR-CM launch contributed approximately $150 million in revenue during Q2[33, 34] - There are approximately 1,400 ATTR-CM patients receiving AMVUTTRA as of June 30, 2025[17, 37, 45] - U S TTR franchise experienced 125% year-over-year growth in Q2[32] - GIVLAARI saw a 30% year-over-year growth, driven by an approximately 18% increase in global patients on therapy[29] - OXLUMO experienced a 15% year-over-year growth, driven by an approximately 16% increase in global patients on therapy[29] Pipeline Development - The TRITON-CM Phase 3 study for nucresiran in ATTR-CM has been initiated, with a targeted launch around 2030[17, 60] - Phase 1 multidose results for mivelsiran in Alzheimer's Disease were announced[17] - A Phase 1 study for ALN-4324 in Type 2 Diabetes was initiated[17]